Reservoir and a series of related reservoirs for use in an electrotransport drug delivery device and devices comprised thereof
AssigneeAlza Corporation
InventorsJoseph B. Phipps, Gary A. Lattin, Larry A. McNichols, John D. Badzinski
Life of this patent
Estimating the term…
Abstract
A reservoir and a family of reservoirs are provided which are designed to be used with a single controller to provide a wide range of therapeutic drug delivering regimens while maintaining many of the same reservoir configurations and drug formulations. A method of making a reservoir and a family of reservoirs and incorporating them into an electrotransport system is disclosed.
Claims20
An agent-containing reservoir for incorporation into an electrotransport delivery system adapted to be placed in agent-transmitting contact with a subject body surface for delivering the agent through the body surface by means of an electrotransport current (i) applied to the reservoir via a reservoir-contacting electrode, the reservoir being permeable to electrically assisted flux of the agent and having:
- (a) a predetermined volume that holds a quantity of the agent sufficient to achieve therapeutically effective delivery of the agent during the entire intended duration of use, wherein the predetermined volume for a given reservoir thickness is defined by the reservoir average cross-sectional area ARES;
- (b) a surface that is placed in contact with the body of the subject during use, the body-contacting surface having an area ABODY that provides at least one of
- (i) a reservoir/body surface current density IBODY, wherein IBODY=i/ABODY, greater than a minimum current density level above which electrotransport delivery Rate/i is approximately maximal and substantially independent of current density occurring at the body-contacting surface during therapeutic use of the device, and
- (ii) a drug flux j that is biocompatible;
- and
- (c) a surface in contact with the electrode, the electrode-contacting surface having an area AELECTRODE that provides a reservoir/electrode current density IELECTRODE, wherein IELECTRODE=i/AELECTRODE, that results in at least one of
- (i) a desired electrochemical reaction along the electrode-contacting surface, and
- (ii) avoidance of undesired polarization along the electrode-contacting surface.
An electrotransport system for delivering an agent through a subject body surface, comprising
- a controller for generating and/or controlling an electrotransport current (i) adapted to be separably coupleable to at least two different types of agent-containing reservoirs, one agent-containing reservoir at a time, the at least two different agent containing reservoirs containing distinct amounts of a single therapeutic agent formulation to achieve different dosing levels, the controller applying the electrotransport current (i) to respective reservoirs in the different types of agent-containing reservoirs via a reservoir-contacting electrode, wherein the respective reservoirs in the different types of agent-containing reservoirs each have:
- (a) a predetermined volume that holds a quantity of the agent sufficient to achieve therapeutically effective delivery of the agent during the entire intended duration of use, wherein the predetermined volume, for a given reservoir thickness is defined by the reservoir average cross-sectional area ARES;
- (b) a surface that is placed in contact with the body of the subject during use, the body-contacting surface having an area ABODY that provides at least one of
- (i) a reservoir/body surface current density IBODY, wherein IBODY=i/ABODY, greater than a minimum current density level above which electrotransport delivery Rate/i is approximately maximal and substantially independent of current density occurring at the body-contacting surface during therapeutic use of the device, and
- (ii) a drug flux j that is biocompatible;
- and
- (c) a surface in contact with the electrode, the electrode-contacting surface having an area AELECTRODE that provides a reservoir/electrode current density IELECTRODE, wherein IELECTRODE=i/AELECTRODE, that results in at least one of
- (i) a desired electrochemical reaction along the electrode-contacting surface, and
- (ii) avoidance of undesired polarization along the electrode-contacting surface.
- wherein ABODY and ARES are different between the distinct agent-containing reservoir types.
A set of therapeutic agent-containing reservoirs for use in an electrotransport drug delivery device, each of said reservoirs in the set containing a distinct amount of a single therapeutic agent formulation to achieve different dosing levels, wherein the respective reservoirs in the set each have:
- (a) a predetermined volume that holds a quantity of the agent sufficient to achieve therapeutically effective delivery of the agent during the entire intended duration of use, wherein the predetermined volume for a given reservoir thickness is defined by the reservoir average cross-sectional area ARES;
- (b) a surface that is placed in contact with the body of the subject during use, the body-contacting surface having an area ABODY that provides at least one of
- (i) a reservoir/body surface current density IBODY, wherein IBODY=i/ABODY, greater than a minimum current density level above which electrotransport delivery Rate/i is approximately maximal and substantially independent of current density occurring at the body-contacting surface during therapeutic use of the device, and
- (ii) a drug flux j that is biocompatible;
- and
- (c) a surface in contact with the electrode, the electrode-contacting surface having an area AELECTRODE that provides a reservoir/electrode current density IELECTRODE, wherein IELECTRODE=i/AELECTRODE, that results in at least one of
- (i) a desired electrochemical reaction along the electrode-contacting surface, and
- (ii) avoidance of undesired polarization along the electrode-contacting surface.
Dependencies are inferred from the claim text.